U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020392

Expand all

CYSTAGON (CYSTEAMINE BITARTRATE)
EQ 50MG BASE
Marketing Status: Prescription
Active Ingredient: CYSTEAMINE BITARTRATE
Proprietary Name: CYSTAGON
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 50MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020392
Product Number: 001
Approval Date: Aug 15, 1994
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
CYSTAGON (CYSTEAMINE BITARTRATE)
EQ 150MG BASE
Marketing Status: Prescription
Active Ingredient: CYSTEAMINE BITARTRATE
Proprietary Name: CYSTAGON
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N020392
Product Number: 002
Approval Date: Aug 15, 1994
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top